Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls

Detalhes bibliográficos
Autor(a) principal: Bavoso,Nádia Couto
Data de Publicação: 2019
Outros Autores: Pinto,Jackson Machado, Soares,Maria Marta Sarquis, Diniz,Michelle dos Santos, Teixeira Júnior,Antônio Lúcio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Anais brasileiros de dermatologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000200192
Resumo: Abstract BACKGROUND: Psoriasis and obesity are somewhat related to a low-grade systemic inflammatory response. OBJECTIVES: To determine leptin and adiponectin levels in psoriasis patients compared to control patients matched for weight. METHODS: A case-control study was performed, evaluating 113 psoriasis patients and 41 controls with other dermatologic diseases. RESULTS: The prevalence of obesity was 33% in cases and 21.9% in controls. All evaluated comorbidities were more prevalent among cases. When stratified by weight, the comorbidities were more frequent in overweight patients. We found no correlation between being overweight (p=0.25), leptin (p=0.18) or adiponectin (p=0.762) levels and psoriasis severity. When overweight cases and controls were compared, we found differences in the adiponectin values (p= 0.04). The overweight cases had lower adiponectin levels than the overweight controls. We found no differences in the leptin dosage between cases and controls. The overweight cases had higher leptin values than the normal weight cases (p<0.001). STUDY LIMITATIONS: Several patients used systemic anti-inflammatory medication. CONCLUSIONS: The prevalence of obesity among psoriasis cases (33%) was higher than in the general population (17.4%). We did not find any correlation between severity of psoriasis and inflammatory cytokines and the condition of being overweight. The overweight cases had lower values of adiponectin than the overweight controls. It seems, therefore, that there is a relationship between adiponectin and psoriasis, but this relationship depends on the presence of obesity.
id SBD-1_7eaa7408892e0d116f614fa540ee1b99
oai_identifier_str oai:scielo:S0365-05962019000200192
network_acronym_str SBD-1
network_name_str Anais brasileiros de dermatologia (Online)
repository_id_str
spelling Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controlsAdiponectinLeptinObesityPsoriasisAbstract BACKGROUND: Psoriasis and obesity are somewhat related to a low-grade systemic inflammatory response. OBJECTIVES: To determine leptin and adiponectin levels in psoriasis patients compared to control patients matched for weight. METHODS: A case-control study was performed, evaluating 113 psoriasis patients and 41 controls with other dermatologic diseases. RESULTS: The prevalence of obesity was 33% in cases and 21.9% in controls. All evaluated comorbidities were more prevalent among cases. When stratified by weight, the comorbidities were more frequent in overweight patients. We found no correlation between being overweight (p=0.25), leptin (p=0.18) or adiponectin (p=0.762) levels and psoriasis severity. When overweight cases and controls were compared, we found differences in the adiponectin values (p= 0.04). The overweight cases had lower adiponectin levels than the overweight controls. We found no differences in the leptin dosage between cases and controls. The overweight cases had higher leptin values than the normal weight cases (p<0.001). STUDY LIMITATIONS: Several patients used systemic anti-inflammatory medication. CONCLUSIONS: The prevalence of obesity among psoriasis cases (33%) was higher than in the general population (17.4%). We did not find any correlation between severity of psoriasis and inflammatory cytokines and the condition of being overweight. The overweight cases had lower values of adiponectin than the overweight controls. It seems, therefore, that there is a relationship between adiponectin and psoriasis, but this relationship depends on the presence of obesity.Sociedade Brasileira de Dermatologia2019-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000200192Anais Brasileiros de Dermatologia v.94 n.2 2019reponame:Anais brasileiros de dermatologia (Online)instname:Sociedade Brasileira de Dermatologia (SBD)instacron:SBD10.1590/abd1806-4841.20197716info:eu-repo/semantics/openAccessBavoso,Nádia CoutoPinto,Jackson MachadoSoares,Maria Marta SarquisDiniz,Michelle dos SantosTeixeira Júnior,Antônio Lúcioeng2019-05-13T00:00:00Zoai:scielo:S0365-05962019000200192Revistahttp://www.anaisdedermatologia.org.br/https://old.scielo.br/oai/scielo-oai.phpabd@sbd.org.br||revista@sbd.org.br1806-48410365-0596opendoar:2019-05-13T00:00Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)false
dc.title.none.fl_str_mv Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
title Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
spellingShingle Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
Bavoso,Nádia Couto
Adiponectin
Leptin
Obesity
Psoriasis
title_short Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
title_full Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
title_fullStr Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
title_full_unstemmed Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
title_sort Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls
author Bavoso,Nádia Couto
author_facet Bavoso,Nádia Couto
Pinto,Jackson Machado
Soares,Maria Marta Sarquis
Diniz,Michelle dos Santos
Teixeira Júnior,Antônio Lúcio
author_role author
author2 Pinto,Jackson Machado
Soares,Maria Marta Sarquis
Diniz,Michelle dos Santos
Teixeira Júnior,Antônio Lúcio
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Bavoso,Nádia Couto
Pinto,Jackson Machado
Soares,Maria Marta Sarquis
Diniz,Michelle dos Santos
Teixeira Júnior,Antônio Lúcio
dc.subject.por.fl_str_mv Adiponectin
Leptin
Obesity
Psoriasis
topic Adiponectin
Leptin
Obesity
Psoriasis
description Abstract BACKGROUND: Psoriasis and obesity are somewhat related to a low-grade systemic inflammatory response. OBJECTIVES: To determine leptin and adiponectin levels in psoriasis patients compared to control patients matched for weight. METHODS: A case-control study was performed, evaluating 113 psoriasis patients and 41 controls with other dermatologic diseases. RESULTS: The prevalence of obesity was 33% in cases and 21.9% in controls. All evaluated comorbidities were more prevalent among cases. When stratified by weight, the comorbidities were more frequent in overweight patients. We found no correlation between being overweight (p=0.25), leptin (p=0.18) or adiponectin (p=0.762) levels and psoriasis severity. When overweight cases and controls were compared, we found differences in the adiponectin values (p= 0.04). The overweight cases had lower adiponectin levels than the overweight controls. We found no differences in the leptin dosage between cases and controls. The overweight cases had higher leptin values than the normal weight cases (p<0.001). STUDY LIMITATIONS: Several patients used systemic anti-inflammatory medication. CONCLUSIONS: The prevalence of obesity among psoriasis cases (33%) was higher than in the general population (17.4%). We did not find any correlation between severity of psoriasis and inflammatory cytokines and the condition of being overweight. The overweight cases had lower values of adiponectin than the overweight controls. It seems, therefore, that there is a relationship between adiponectin and psoriasis, but this relationship depends on the presence of obesity.
publishDate 2019
dc.date.none.fl_str_mv 2019-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000200192
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962019000200192
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/abd1806-4841.20197716
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
publisher.none.fl_str_mv Sociedade Brasileira de Dermatologia
dc.source.none.fl_str_mv Anais Brasileiros de Dermatologia v.94 n.2 2019
reponame:Anais brasileiros de dermatologia (Online)
instname:Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
instname_str Sociedade Brasileira de Dermatologia (SBD)
instacron_str SBD
institution SBD
reponame_str Anais brasileiros de dermatologia (Online)
collection Anais brasileiros de dermatologia (Online)
repository.name.fl_str_mv Anais brasileiros de dermatologia (Online) - Sociedade Brasileira de Dermatologia (SBD)
repository.mail.fl_str_mv abd@sbd.org.br||revista@sbd.org.br
_version_ 1752126423368204288